VivaCell supports the II Meeting of Traslational Research on Rare Diseases at IMIBIC

14/11/2016

Córdoba, November 14th 2016. Along with other pharmaceutical companies such as Novartis and Sanofi Genzyme, VivaCell supports the II Meeting of Translational Research on Rare Diseases at Instituto Maimonides de Investigación Biomédica at Córdoba, Spain. The conference, hold past weekend, is dedicated to neuromuscular diseases within the framework of the National Day of Neuromuscular Diseases. VivaCell is currently evaluating the effect of several candidates as drugs for the treatment of Amyotrophic Lateral Sclerosis. With this support VivaCell shows the strong commitment with the scientific research on rare diseases.

Más información:

Developed with DoPlanning